Veeva Systems Drives Innovative Medtech Solutions and Data Integrity
Understanding the Latest Trends in Medtech Collaborations
In an era where efficiency is paramount, nearly 70% of medtech companies are prioritizing strategies to minimize manual processes when collaborating with research sites. This statistic reveals a significant shift in focus towards streamlining operations, enhancing data quality, and increasing oversight within clinical trials.
Key Insights from the 2025 Veeva MedTech Clinical Benchmark
The recent evaluations provided by Veeva Systems (NYSE: VEEV) highlight that medtech clinical teams are committed to optimizing their interactions with research sites. The benchmark report illustrates a critical emphasis on reducing manual interventions (68% of respondents), improving the overall quality of studies (56%), and achieving better visibility in operations (55%). By embracing these changes, companies can leverage technology effectively, creating more standardized clinical processes and accelerating trial timelines.
Challenges Within Site Management
Despite the advancements, the report identified key challenges hindering site management. Respondents pointed out that on-time data entry, document exchange, and compliance issues pose substantial hurdles. Alarmingly, only 14% of medtech firms with revenues over $1 billion have implemented site collaboration tools, and this rises to 24% for those below that revenue threshold. This highlights a considerable gap in resources as the industry seeks to enhance trial efficiency.
Towards Greater Efficiency: A Move to Data Optimization
As medtech teams navigate the complexities of clinical trials, various insights emerge about their working environment. Respondents noted that reliance on manual processes (32%), compliance with global regulations (18%), and preparing for inspections (18%) are pressing challenges. The high dependence on manual workflows not only escalates operational costs but also contributes to delays in trial progress.
The Rising Focus on Data Collection
To combat these obstacles, it's promising to see that 58% of medtech organizations have made it a priority to enhance data collection and cleansing processes over the next year. By doing so, they aim to minimize time spent on data reconciliation, allowing teams to dedicate more resources to high-value activities within clinical trials.
Embracing AI and Machine Learning
While there are hurdles, there's also a significant push towards innovation. Approximately 72% of medtech firms are planning investments in AI and machine learning infrastructure, striving to harmonize existing systems and standardize data for better integration. This adaptability showcases the industry's commitment to modernizing operations and improving the quality of outcomes.
Kevin Liang, vice president of clinical strategy at Veeva MedTech, expressed, "The medtech industry is actively pursuing advancements in clinical processes through enhanced collaboration and data quality, especially in the face of economic challenges and evolving regulations." His insights reflect the broader industry trend of prioritizing data integrity and operational efficiency, aimed at speeding new technologies to patients.
The findings from the 2025 Veeva MedTech Clinical Benchmark surveyed over 100 clinical professionals in the medical device and diagnostics sectors, painting a comprehensive picture of today's medtech landscape. The report serves as a valuable resource for understanding how clinical teams are adapting to modern challenges while working towards improving their operations.
Frequently Asked Questions
What is the main focus of the 2025 Veeva MedTech Clinical Benchmark?
The benchmark focuses on the operational priorities of medtech companies, emphasizing collaboration with research sites, data quality improvement, and reducing manual processes.
How are medtech companies addressing manual processes?
Many companies are prioritizing the implementation of technology to standardize clinical workflows, which helps minimize manual interventions and operational costs.
What challenges do clinical teams face according to the report?
Key challenges include on-time data entry, document exchange, regulatory compliance, and the lack of site collaboration tools.
Is there a shift towards using AI in medtech?
Yes, a notable 72% of medtech organizations plan to invest in AI and machine learning to enhance system integration and data standardization.
How can Veeva MedTech assist companies?
Veeva MedTech aids medical device and diagnostics firms to streamline all stages of product development and commercialization to speed up the delivery of medical products to patients.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
